111 filings
6-K
FRPRQ
4D Pharma PLC
23 Feb 23
Notice of Cancellation of Admission to Trading on Aim
3:30pm
6-K
FRPRQ
4D Pharma PLC
17 Feb 23
Current report (foreign)
2:51pm
6-K
FRPRQ
4D Pharma PLC
7 Feb 23
Current report (foreign)
3:17pm
6-K
FRPRQ
4D Pharma PLC
3 Jan 23
4D pharma Announces an Update on Administration and Suspension of Trading
12:09pm
6-K
FRPRQ
4D Pharma PLC
18 Nov 22
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics
2:58pm
6-K
FRPRQ
4D Pharma PLC
15 Nov 22
Current report (foreign)
1:53pm
6-K
FRPRQ
4D Pharma PLC
7 Oct 22
Current report (foreign)
10:58am
6-K
FRPRQ
4D Pharma PLC
30 Sep 22
Delay to publication of Interim Results
3:04pm
6-K
FRPRQ
4D Pharma PLC
24 Aug 22
Current report (foreign)
5:06pm
6-K
FRPRQ
4D Pharma PLC
24 Aug 22
Delisting of Securities of 4D pharma plc from The Nasdaq Stock Market
4:56pm
6-K
FRPRQ
4D Pharma PLC
24 Aug 22
4D pharma Announces Publication of Preclinical Research Showing Live Biotherapeutic MRx0006 Efficacy in Animal Model of Autism Spectrum Disorder
4:43pm
25-NSE
FRPRQ
4D Pharma PLC
19 Jul 22
Exchange delisting
11:48am
6-K
FRPRQ
4D Pharma PLC
5 Jul 22
Current report (foreign)
2:06pm
6-K
FRPRQ
4D Pharma PLC
29 Jun 22
Current report (foreign)
2:25pm
6-K
FRPRQ
4D Pharma PLC
24 Jun 22
Update on Suspension of Trading
5:19pm
6-K
FRPRQ
4D Pharma PLC
24 Jun 22
Current report (foreign)
9:19am
6-K
FRPRQ
4D Pharma PLC
1 Jun 22
Current report (foreign)
3:31pm
EFFECT
FRPRQ
4D Pharma PLC
29 Apr 22
Notice of effectiveness
12:15am
UPLOAD
FRPRQ
4D Pharma PLC
26 Apr 22
Letter from SEC
12:00am
CORRESP
FRPRQ
4D Pharma PLC
26 Apr 22
Correspondence with SEC
12:00am